Biohaven’s Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint Read more
FDA Grants Priority Review for Kite’s KTE-X19 BLA in Relapsed or Refractory Mantle Cell Lymphoma Read more
AI in Drug Discovery to host panel discussion on “The AI Paradigm Shift – is it just a hype?” Read more